{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-109803","form_type":"8-K","ticker":"RPID","cik":"0001380106","company_name":"RAPID MICRO BIOSYSTEMS, INC.","filed_at":"2021-08-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.894784+00:00","generated_at":"2026-06-29T07:31:02.262073+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Rapid Micro Q2 commercial revenue $5.7M (+135% YoY); full-year outlook at least $24M","bullets":["Q2 total revenue $6.1M vs $2.6M YoY; net loss ($11.8M) vs ($9.3M) YoY.","Placed 8 new systems (cumulative 103); validated 11 systems (cumulative 63).","Sold one-millionth consumable since Growth Direct commercial launch.","Completed IPO in July 2021: ~9M shares sold, $165.3M net proceeds; pro forma cash ~$260M.","Full-year 2021 commercial revenue guidance: at least $24.0M (≥70% YoY growth)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-109803","json":"https://secwatch.observer/filing/0001104659-21-109803.json","markdown":"https://secwatch.observer/filing/0001104659-21-109803.md","text":"https://secwatch.observer/filing/0001104659-21-109803.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1380106/000110465921109803/0001104659-21-109803-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1380106/000110465921109803/tm2125995d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T07:31:02.262073+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}